Hematology/Oncology News

The addition of a pre-ketone supplement to an immunotherapy regimen demonstrated efficacy for treating prostate cancer, according to a study led by researchers at University of Notre Dame.

The FDA approved vorasidenib for certain patients with astrocytoma or oligodendroglioma.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, discusses the results of the FIREFLY-1 (NCT04775485) trial she presented at International Symposium on Pediatric Neuro-Oncology.

Patients who underwent liver transplantation vs. alternative therapy for unresectable colorectal liver metastasis had higher progression-free and overall survival, as well as lower rates of recurrence, researchers reported in JAMA Surgery.

Latin American patients with rheumatoid arthritis experience fewer serious adverse events, including major adverse cardiovascular events and malignancy, than patients who are not Latin American, according to a study.

Neha Vapiwala, MD, FACR, FASTRO, FASCO, has been named president-elect of the American Society for Radiation Oncology.

The socioeconomic status of cell donors may affect outcomes of people with blood cancer who undergo hematopoietic stem cell transplantation, according to retrospective study results.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, highlights keynote addresses from International Symposium on Pediatric Neuro-Oncology.

Women with breast cancer who underwent hormone-modulating therapy exhibited a reduced risk for Alzheimer’s disease and related dementias, according to results of a retrospective cohort study.

The level of trust American adults have in cancer information from government health agencies declined significantly since the start of the COVID-19 pandemic, according to results of a cross-sectional study.